A Phase 1 Open Label, Dose Escalation Study to Evaluate the Safety and Tolerability of Latanoprost Sustained Release Insert in Patients with Primary Open Angle Glaucoma or Ocular Hypertension

  • Deokule, Sunil (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date6/1/103/31/12